Ralliant Corporation RAL
Regular-session close
After hours · Nov 19, 4:07 PM ET
- YTD
- +28.93%
- 1 year
- +42.51%
Fundamental scorecard
6 of 25 checks passed on RAL’s reported financials
6of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 2 of 5
- Dividend 2 of 5
Statements to Oct 2, 2026.
Value 1 of 5
- Failed:P/E below its own 5-year median No profit over the last 12 months, so no P/E.
- Failed:P/E under 20 No profit over the last 12 months, so no P/E.
- No data:Price to sales below its own 5-year median Price to sales 3.2. Not enough data to decide.
- No data:Price to book below its own 5-year median Price to book 4.5. Not enough data to decide.
- Passed:Free cash flow yield above 4% Free cash flow of 303M is 4.2% of the market value.
Growth 1 of 5
- Passed:Revenue grew over the last year Revenue of 2.28B is +10.4% on the 12 months before.
- Failed:Revenue grew more than 5% a year over five years -5.1% a year from FY 1999 to FY 2025.
- Failed:Earnings per share grew over the last year EPS -10.51 against 2.08 in the 12 months before.
- Failed:Earnings per share grew more than 5% a year over five years EPS 1.60 in FY 1999, -10.84 in FY 2025.
- No data:Analysts expect higher earnings per share over the next year No analyst estimate.
Profitability 0 of 5
- Failed:Profitable over the last year Net income of -1.19B over the last 12 months.
- Failed:Profitable in each of the last five fiscal years A profit in 4 of the last 5 fiscal years.
- Failed:Return on equity above 15% Return on equity of -51.8%.
- Failed:Net margin above its 5-year average Net margin of -52.1% against a 5-year average of 2.7%.
- Failed:Free cash flow is at least 80% of net income No profit over the last 12 months to compare with.
Financial health 2 of 5
- Passed:Short-term assets cover short-term liabilities Short-term assets of 1.11B against short-term liabilities of 674M.
- Failed:Short-term assets cover long-term liabilities Short-term assets of 1.11B against long-term liabilities of 1.52B.
- Failed:Net debt under 40% of equity Net debt of 783M is 48.4% of equity.
- Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 338M is 29.4% of debt.
- Failed:Operating profit covers interest at least 3 times Operating profit is -19.0 times the interest expense.
Dividend 2 of 5
- Passed:Pays a dividend 22.4M paid over the last 12 months.
- Failed:Yield above 1.5% A yield of 0.3% at the current market value.
- Failed:Pays out under 75% of profit Paid while the company made no profit over the last 12 months.
- Passed:Covered by free cash flow 7.4% of free cash flow is paid out.
- Failed:Not cut in the last five fiscal years The total paid fell in 2 of the last five fiscal years.
Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Financial position
What RAL owns and owes, as of Oct 2, 2026
Short term and long term
Balance sheet · 3.81B of assets
Debt, equity and cash by year
Now: 783M of debt after cash
Fiscal years, then the newest quarter. Cash includes short-term investments.
From the company’s SEC filings.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
1.37 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
Profitability
Growth (YoY)
Financial Health
Dividends
Annual · latest fiscal year ends 2025-12-31
